OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification and evaluation of glutathione conjugate gamma-l-glutamyl-l-cysteine for improved drug delivery to the brain
Saman Fatima, Taj Mohammad, Deeba Shamim Jairajpuri, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 12, pp. 3610-3620
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

A Historical Review of Brain Drug Delivery
William M. Pardridge
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1283-1283
Open Access | Times Cited: 127

Studying the interaction of drug/ligand with serum albumin
Sharmin Siddiqui, Faisal Ameen, Sayeed Ur Rehman, et al.
Journal of Molecular Liquids (2021) Vol. 336, pp. 116200-116200
Closed Access | Times Cited: 105

Biophysical insight into the binding mechanism of doxofylline to bovine serum albumin: An in vitro and in silico approach
Sharmin Siddiqui, Faisal Ameen, Tasneem Kausar, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2020) Vol. 249, pp. 119296-119296
Closed Access | Times Cited: 80

Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations
Deeba Shamim Jairajpuri, Afzal Hussain, Khalida Nasreen, et al.
Saudi Journal of Biological Sciences (2021) Vol. 28, Iss. 4, pp. 2423-2431
Open Access | Times Cited: 69

Blood–Brain Barrier- and Blood–Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases
Long Chen, Lingfang Zeng, Nuo Xu, et al.
ACS Applied Materials & Interfaces (2019) Vol. 11, Iss. 45, pp. 41889-41897
Closed Access | Times Cited: 74

Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy
Preeti Gupta, Taj Mohammad, Rashmi Dahiya, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 63

Brain Delivery of Single-Domain Antibodies: A Focus on VHH and VNAR
Elodie Pothin, Dominique Lesuisse, Pierre Lafaye
Pharmaceutics (2020) Vol. 12, Iss. 10, pp. 937-937
Open Access | Times Cited: 62

Blood-brain barrier delivery for lysosomal storage disorders with IgG-lysosomal enzyme fusion proteins
William M. Pardridge
Advanced Drug Delivery Reviews (2022) Vol. 184, pp. 114234-114234
Open Access | Times Cited: 27

Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy
Taj Mohammad, Sagar Batra, Rashmi Dahiya, et al.
Molecules (2019) Vol. 24, Iss. 24, pp. 4589-4589
Open Access | Times Cited: 49

Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies
Asifa Khan, Taj Mohammad, Anas Shamsi, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10319-10331
Closed Access | Times Cited: 36

Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency
Ahmed L. Alaofi, Mudassar Shahid
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1273-1273
Open Access | Times Cited: 36

Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
Alaa Shafie, Shama Khan, Zehra, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2157-2157
Open Access | Times Cited: 36

Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase
Farah Anjum, Taj Mohammad, Abdulraheem Ali Almalki, et al.
OMICS A Journal of Integrative Biology (2021) Vol. 25, Iss. 9, pp. 580-590
Closed Access | Times Cited: 35

New Drug Delivery Systems Developed for Brain Targeting
Shruti Rawal, Bhoomika M. Patel, Mayur M. Patel
Drugs (2022) Vol. 82, Iss. 7, pp. 749-792
Closed Access | Times Cited: 26

Glutathione targeted tragacanthic acid-chitosan as a non-viral vector for brain delivery of miRNA-219a-5P: An in vitro/in vivo study
Nahal Shamaeizadeh, Jaleh Varshosaz, Mina Mirian, et al.
International Journal of Biological Macromolecules (2022) Vol. 200, pp. 543-556
Closed Access | Times Cited: 25

Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics
Farah Anjum, Md Nayab Sulaimani, Alaa Shafie, et al.
RSC Advances (2022) Vol. 12, Iss. 13, pp. 7872-7882
Open Access | Times Cited: 25

Mechanistic Insight into Binding of Huperzine A with Human Serum Albumin: Computational and Spectroscopic Approaches
Anas Shamsi, Moyad Shahwan, Mohd Shahnawaz Khan, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 797-797
Open Access | Times Cited: 23

Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain
William M. Pardridge
Frontiers in Medical Technology (2020) Vol. 2
Open Access | Times Cited: 29

Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancer
Taj Mohammad, Kaynat Arif, Mohamed F. Alajmi, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 2, pp. 586-594
Closed Access | Times Cited: 27

A multi-spectroscopic and computational simulations study to delineate the interaction between antimalarial drug hydroxychloroquine and human serum albumin
Kashish Azeem, Mofieed Ahmed, Taj Mohammad, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 13, pp. 6377-6393
Closed Access | Times Cited: 16

Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach
Bader S. Alotaibi, Jatin Joshi, Mohammad Raghibul Hasan, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 14, pp. 6749-6758
Closed Access | Times Cited: 16

Enhanced penetration of pro-apoptotic and anti-angiogenic micellar nanoprobe in 3D multicellular spheroids for chemophototherapy
Anbu Mozhi, Vishnu Sunil, Wenbo Zhan, et al.
Journal of Controlled Release (2020) Vol. 323, pp. 502-518
Open Access | Times Cited: 26

Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy
Mohd Adnan, Anas Shamsi, Abdelbaset Mohamed Elasbali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13172-13172
Open Access | Times Cited: 14

Impact of non-synonymous mutations on the structure and function of telomeric repeat binding factor 1
Insan Habib, Shama Khan, Taj Mohammad, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 19, pp. 9053-9066
Closed Access | Times Cited: 19

Page 1 - Next Page

Scroll to top